Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of R115777 (Zarnestra) in Combination With Induction Chemotherapy in Patients With Newly Diagnosed, High Risk Acute Myeloid Leukemia

NCT00124644 is registered in ClinicalTrials.gov with Ohio State University Comprehensive Cancer Center as lead sponsor.

NCT NCT00124644
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00124644 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of R115777 (Zarnestra) in Combination With Induction Chemotherapy in Patients With Newly Diagnosed, High Risk Acute Myeloid Leukemia
Lead sponsor
Ohio State University Comprehensive Cancer Center
Phase
Phase 1
Overall status
Terminated
Start date
March 31, 2006
Completion date
January 31, 2008
Enrollment
30
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia